Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-04-02 Sale | 2025-04-03 4:27 pm | Inozyme Pharma Inc. | INZY | Treco Douglas A CEO & Chairman | 8,819 | $0.89 | $7,849 | 91,046 (Direct) | View |
| 2024-04-02 Sale | 2024-04-03 5:23 pm | Inozyme Pharma Inc. | INZY | Treco Douglas A CEO | 7,523 | $6.94 | $52,210 | 95,665 (Direct) | View |
| 2023-08-01 Purchase | 2023-08-03 8:13 pm | Inozyme Pharma Inc. | INZY | Pivotal bioVenture Partners Fund I L.P. Pivotal bioVenture Partners Fund I G.P. L.P. Pivotal bioVenture Partners Fund I U.G.P. Ltd Director | 833,333 | $4.8 | $3,999,998 | 1,571,741 (Indirect) | View |
| 2023-08-01 Purchase | 2023-08-03 8:01 pm | Inozyme Pharma Inc. | INZY | Hopfner Robert Lorne Director | 833,333 | $4.8 | $3,999,998 | 1,571,741 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-07-01 Equity Swap | 2025-07-03 7:16 pm | N/A N/A | Inozyme Pharma Inc. | INZY | Subramanian Sanjay SVP, CFO & Head of BD | 39,701 | $4 | 0 (Direct) | View |
| 2025-07-01 Equity Swap | 2025-07-03 7:08 pm | N/A N/A | Inozyme Pharma Inc. | INZY | Winton Matthew COO | 21,743 | $4 | 0 (Direct) | View |
| 2025-07-01 Equity Swap | 2025-07-03 7:07 pm | N/A N/A | Inozyme Pharma Inc. | INZY | Bolte Axel Director | 423,926 | $4 | 0 (Direct) | View |
| 2025-07-01 Equity Swap | 2025-07-03 7:03 pm | N/A N/A | Inozyme Pharma Inc. | INZY | Treco Douglas A CEO & Chairman | 43,861 | $4 | 0 (Direct) | View |
| 2025-07-01 Equity Swap | 2025-07-03 6:59 pm | N/A N/A | Inozyme Pharma Inc. | INZY | Hopfner Robert Lorne Director | 4,494,851 | $4 | 0 (Indirect) | View |
| 2025-06-25 Option Award | 2025-06-27 4:05 pm | N/A N/A | Inozyme Pharma Inc. | INZY | Winton Matthew COO | 14,355 | $0.74 | 21,743 (Direct) | View |
| 2025-06-25 Option Award | 2025-06-27 4:05 pm | N/A N/A | Inozyme Pharma Inc. | INZY | Treco Douglas A CEO & Chairman | 2,815 | $0.74 | 43,861 (Direct) | View |
| 2025-06-25 Option Award | 2025-06-27 4:05 pm | N/A N/A | Inozyme Pharma Inc. | INZY | Subramanian Sanjay SVP, CFO & Head of BD | 6,813 | $0.74 | 39,701 (Direct) | View |
| 2025-05-15 Exercise | 2025-05-20 4:00 pm | N/A N/A | Inozyme Pharma Inc. | INZY | Bolte Axel Director | 157,230 | $0.98 | 423,926 (Direct) | View |
| 2025-05-15 Exercise | 2025-05-20 4:00 pm | N/A 2027-06-27 | Inozyme Pharma Inc. | INZY | Bolte Axel Director | 157,230 | $0 | 423,926 (Direct) | View |
| 2025-04-01 Exercise | 2025-04-03 4:27 pm | N/A N/A | Inozyme Pharma Inc. | INZY | Treco Douglas A CEO & Chairman | 25,000 | $0 | 91,046 (Direct) | View |
| 2025-03-31 Option Award | 2025-04-02 4:29 pm | N/A N/A | Inozyme Pharma Inc. | INZY | Winton Matthew COO | 2,490 | $0.77 | 7,388 (Direct) | View |
| 2025-03-31 Option Award | 2025-04-02 4:27 pm | N/A N/A | Inozyme Pharma Inc. | INZY | Subramanian Sanjay SVP, CFO & Head of BD | 2,490 | $0.77 | 32,888 (Direct) | View |
| 2025-03-11 Option Award | 2025-03-17 4:26 pm | N/A 2035-03-10 | Inozyme Pharma Inc. | INZY | Subramanian Sanjay SVP, CFO | 183,500 | $0 | 183,500 (Direct) | View |
| 2025-03-11 Option Award | 2025-03-17 4:25 pm | N/A 2035-03-10 | Inozyme Pharma Inc. | INZY | Winton Matthew COO | 186,500 | $0 | 186,500 (Direct) | View |
| 2025-03-11 Option Award | 2025-03-17 4:24 pm | N/A 2035-03-10 | Inozyme Pharma Inc. | INZY | Treco Douglas A CEO | 500,000 | $0 | 500,000 (Direct) | View |
| 2024-10-03 Option Award | 2024-10-07 4:37 pm | N/A 2034-10-02 | Inozyme Pharma Inc. | INZY | Harris Erik Director | 56,000 | $0 | 56,000 (Direct) | View |
| 2024-09-30 Option Award | 2024-10-03 8:58 pm | N/A N/A | Inozyme Pharma Inc. | INZY | Treco Douglas A CEO | 1,710 | $4.45 | 22,375 (Direct) | View |
| 2024-09-30 Option Award | 2024-10-03 8:57 pm | N/A N/A | Inozyme Pharma Inc. | INZY | Winton Matthew COO | 1,710 | $4.45 | 4,898 (Direct) | View |
| 2024-06-18 Option Award | 2024-06-20 4:30 pm | N/A 2034-06-17 | Inozyme Pharma Inc. | INZY | Mathers Edward T Director | 28,000 | $0 | 28,000 (Direct) | View |
| 2024-06-18 Option Award | 2024-06-20 4:15 pm | N/A 2034-06-17 | Inozyme Pharma Inc. | INZY | Hopfner Robert Lorne Director | 28,000 | $0 | 28,000 (Direct) | View |
| 2024-06-18 Option Award | 2024-06-20 4:14 pm | N/A 2034-06-17 | Inozyme Pharma Inc. | INZY | DIAZ REINALDO M Director | 28,000 | $0 | 28,000 (Direct) | View |
| 2024-06-18 Option Award | 2024-06-20 4:12 pm | N/A 2034-06-17 | Inozyme Pharma Inc. | INZY | Sullivan Lynne Marie Director | 28,000 | $0 | 28,000 (Direct) | View |
| 2024-06-18 Option Award | 2024-06-20 4:11 pm | N/A 2034-06-17 | Inozyme Pharma Inc. | INZY | Bhagat Sarah M Director | 28,000 | $0 | 28,000 (Direct) | View |
| 2024-06-18 Option Award | 2024-06-20 4:09 pm | N/A 2034-06-17 | Inozyme Pharma Inc. | INZY | Bolte Axel Director | 28,000 | $0 | 28,000 (Direct) | View |
| 2024-06-18 Option Award | 2024-06-20 4:07 pm | N/A 2034-06-17 | Inozyme Pharma Inc. | INZY | Edwards Martin Director | 28,000 | $0 | 28,000 (Direct) | View |
| 2024-04-01 Exercise | 2024-04-03 5:23 pm | N/A N/A | Inozyme Pharma Inc. | INZY | Treco Douglas A CEO | 25,000 | $0 | 95,665 (Direct) | View |
| 2024-03-28 Option Award | 2024-04-03 5:23 pm | N/A N/A | Inozyme Pharma Inc. | INZY | Winton Matthew COO | 3,188 | $3.33 | 3,188 (Direct) | View |
| 2024-03-13 Option Award | 2024-03-15 08:30 am | N/A 2034-03-12 | Inozyme Pharma Inc. | INZY | Winton Matthew COO | 175,000 | $0 | 175,000 (Direct) | View |
| 2024-03-13 Option Award | 2024-03-15 08:30 am | N/A 2034-03-12 | Inozyme Pharma Inc. | INZY | Treco Douglas A CEO | 300,000 | $0 | 300,000 (Direct) | View |
| 2024-03-13 Option Award | 2024-03-15 08:30 am | N/A 2034-03-12 | Inozyme Pharma Inc. | INZY | Subramanian Sanjay SVP, CFO | 165,000 | $0 | 165,000 (Direct) | View |
| 2023-09-29 Option Award | 2023-10-03 4:05 pm | N/A N/A | Inozyme Pharma Inc. | INZY | Subramanian Sanjay SVP, CFO | 2,319 | $3.57 | 30,398 (Direct) | View |
| 2023-06-13 Option Award | 2023-06-15 4:16 pm | N/A 2033-06-12 | Inozyme Pharma Inc. | INZY | Mathers Edward T Director | 16,000 | $0 | 16,000 (Direct) | View |
| 2023-06-13 Option Award | 2023-06-15 4:05 pm | N/A 2033-06-12 | Inozyme Pharma Inc. | INZY | Sullivan Lynne Marie Director | 16,000 | $0 | 16,000 (Direct) | View |
| 2023-06-13 Option Award | 2023-06-15 4:05 pm | N/A 2033-06-12 | Inozyme Pharma Inc. | INZY | DIAZ REINALDO M Director | 16,000 | $0 | 16,000 (Direct) | View |
| 2023-06-13 Option Award | 2023-06-15 4:05 pm | N/A 2033-06-12 | Inozyme Pharma Inc. | INZY | Hopfner Robert Lorne Director | 16,000 | $0 | 16,000 (Direct) | View |
| 2023-06-13 Option Award | 2023-06-15 4:05 pm | N/A 2033-06-12 | Inozyme Pharma Inc. | INZY | Edwards Martin Director | 16,000 | $0 | 16,000 (Direct) | View |